NLS

A government report on the future of life science in Sweden in part calls for strong academics, positive growth conditions for businesses and government support to sustain industry gains. The report, “A Competitive Ecosystem for Life Science,” is the result of meetings with 80 organizations and companies in Sweden’s life science sector and looks at […]

An influenza drug created by Japan’s Fujifilm Holding Corp. could be approved to treat Ebola by the end of this year. The drug, Avigan, already has been used in Norway, France, Germany and Spain to treat Ebola patients. It was approved in Japan earlier this year to counter new forms of influenza. “So far, four […]

The Human Protein Atlas portal is a publicly available database with millions of high-resolution images showing the spatial distribution of proteins in 44 different normal human tissues and 20 different cancer types, as well as 46 different human cell lines, according to its web site. The data is released together with application-specific validation performed for […]

The Research Council of Norway’s Programme for Global Health and Vaccination Research (GLOBVAC) is helping more newborn children survive and reducing the number of deaths from malaria in low- and lower-middle income countries. Through one programme, midwives working in the delivery rooms of Haydom Lutheran Hospital in a remote area of Tanzania are instructed in […]

Genmab A/S (OMX: GEN) announced that the French Intergroup of Myeloma (IFM) in collaboration with Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and Janssen Biotech, Inc. is planning an additional Phase III study of daratumumab in frontline multiple myeloma. The study will compare daratumumab in combination with bortezomib, thalidomide and dexamethasone (VTD) to bortezomib, […]

This week Novo Nordisk launched NovoRapid® PumpCart®, the first prefilled pump cartridge with an insulin analogue specifically designed for insulin pumps, according to the company web site. This new treatment solution, which contains NovoRapid® (insulin aspart) – a rapid-acting insulin from Novo Nordisk – is expected to make insulin pump therapy more convenient for people with diabetes […]